DAFNA Capital Management

What is DAFNA Capital Management?

DAFNA Capital Management, LLC is a Los Angeles-based SEC-registered investment advisor specializing in managing long/short portfolios of predominantly publicly traded biotechnology and medical device companies. Founded in 1999, DAFNA Capital Management has over 25 years of experience funding the future of medicine and prudently managing the wealth entrusted to them by their investors.

DAFNA Capital Management’s principal mission is capital preservation and strong annualized return over longer time periods with minimum risk. They generate investment returns by recognizing their responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions. They focus on small or mid-capitalization companies with focused pipelines or businesses, and they invest primarily in companies based in the United States or other developed countries.

The firm's investment approach is centered on preventive, diagnostic, and therapeutic interventions that are at the frontiers of science and are leading efforts to improve clinical care. They take pride in building a business with a long-standing track record, significant alpha generation without leverage, and high liquidity. DAFNA’s management team aligns their interests by having the majority of their wealth invested alongside investors.

They also boast extensive scientific and financial expertise in the life science industry, solid operations, and reputable top-tier auditors and other service providers. The firm is also noted for its focused expertise in life science investments, specifically in small to mid-capitalization companies with promising medical advancements.